146 related articles for article (PubMed ID: 32566799)
41. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
Hajiabadi M; Alimohamadi M; Fahlbusch R
World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
[TBL] [Abstract][Full Text] [Related]
42. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
[TBL] [Abstract][Full Text] [Related]
43. Visual acuity and 10 degrees automated static perimetry in eyes with retinitis pigmentosa.
Abe K; Iijima H; Hirakawa H; Tsukahara Y; Toda Y
Jpn J Ophthalmol; 2002; 46(5):581-5. PubMed ID: 12457920
[TBL] [Abstract][Full Text] [Related]
44. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
45. Unilateral retinitis pigmentosa. A case report.
Nazar C; Feldman M; González R; Espinoza R
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):287-290. PubMed ID: 27793487
[TBL] [Abstract][Full Text] [Related]
46. Visual field defects in patients with pituitary adenomas.
Huang WC; Lee LS
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
[TBL] [Abstract][Full Text] [Related]
47. Metastatic paraganglioma presenting as ajunctional scotoma.
Khodeiry MM; Lind JT; Pasol J; Lam BL; Lee RK
Am J Ophthalmol Case Rep; 2022 Mar; 25():101253. PubMed ID: 35036631
[TBL] [Abstract][Full Text] [Related]
48. Reduced Field-of-View Diffusion Tensor Imaging of the Optic Nerve in Retinitis Pigmentosa at 3T.
Zhang Y; Guo X; Wang M; Wang L; Tian Q; Zheng D; Shi D
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1510-5. PubMed ID: 27056427
[TBL] [Abstract][Full Text] [Related]
49. Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa.
Borkenstein AF; Borkenstein EM
Case Rep Ophthalmol; 2019; 10(3):304-311. PubMed ID: 31762761
[TBL] [Abstract][Full Text] [Related]
50. Chronic chiasmal compression and persistent visual field defect without detectable changes in optical coherence tomography of the macular ganglion cell complex.
Lukewich MK; Micieli JA
Am J Ophthalmol Case Rep; 2019 Dec; 16():100533. PubMed ID: 31467999
[TBL] [Abstract][Full Text] [Related]
51. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.
Lee DK; Sung MS; Park SW
Korean J Ophthalmol; 2018 Dec; 32(6):488-496. PubMed ID: 30549473
[TBL] [Abstract][Full Text] [Related]
52. Visual Outcomes in Japanese Patients with Retinitis Pigmentosa and Usher Syndrome Caused by USH2A Mutations.
Nagase Y; Kurata K; Hosono K; Suto K; Hikoya A; Nakanishi H; Mizuta K; Mineta H; Minoshima S; Hotta Y
Semin Ophthalmol; 2018; 33(4):560-565. PubMed ID: 28678594
[TBL] [Abstract][Full Text] [Related]
53. Phenotypic expansion and progression of SPATA7-associated retinitis pigmentosa.
Sengillo JD; Lee W; Bilancia CG; Jobanputra V; Tsang SH
Doc Ophthalmol; 2018 Apr; 136(2):125-133. PubMed ID: 29411205
[TBL] [Abstract][Full Text] [Related]
54. Patterns of visual field progression in patients with retinitis pigmentosa.
Grover S; Fishman GA; Brown J
Ophthalmology; 1998 Jun; 105(6):1069-75. PubMed ID: 9627658
[TBL] [Abstract][Full Text] [Related]
55. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
[TBL] [Abstract][Full Text] [Related]
56. Retinitis pigmentosa inversa.
Ferrucci S; Anderson SF; Townsend JC
Optom Vis Sci; 1998 Aug; 75(8):560-70. PubMed ID: 9734800
[TBL] [Abstract][Full Text] [Related]
57. Sustained improvement in vision in a recurrent growth hormone secreting macroadenoma during treatment with octreotide in the absence of marked tumour shrinkage.
Lindsay JR; Harding JA; Ellis PK; Sheridan B; Atkinson AB
Pituitary; 2003; 6(4):209-14. PubMed ID: 15237932
[TBL] [Abstract][Full Text] [Related]
58. Developed diplopia and ptosis due to a nonfunctioning pituitary macroadenoma during pregnancy.
Lee HR; Song JE; Lee KY
Obstet Gynecol Sci; 2014 Jan; 57(1):66-9. PubMed ID: 24596820
[TBL] [Abstract][Full Text] [Related]
59. A pilot study of an acupuncture protocol to improve visual function in retinitis pigmentosa patients.
Bittner AK; Gould JM; Rosenfarb A; Rozanski C; Dagnelie G
Clin Exp Optom; 2014 May; 97(3):240-7. PubMed ID: 24773463
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
Cennamo G; Auriemma RS; Cardone D; Grasso LF; Velotti N; Simeoli C; Di Somma C; Pivonello R; Colao A; de Crecchio G
Eye (Lond); 2015 Jun; 29(6):797-802. PubMed ID: 25853400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
